BIOTECHNOLOGY VALUE FUND L P SEC Filings

Filed On	Filing
05 Oct 2026	SCHEDULE 13G/A
05 Oct 2026	Form 3: Bvf Partners L P/IL, 10% owner and 9 others · Foghorn Therapeutics Inc Holds 4,494,462 shares of Common Stock, $0.0001 par value per share
30 Sep 2026	SCHEDULE 13G
21 Sep 2026	SCHEDULE 13G
18 Sep 2026	SCHEDULE 13G
18 Sep 2026	Form 4: Bvf Partners L P/IL, Director and 9 others · Immunic Inc Granted 25,370 Stock Option
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	SCHEDULE 13G/A
14 Aug 2026	SCHEDULE 13G/A
12 Aug 2026	SCHEDULE 13G
04 Aug 2026	SCHEDULE 13D
20 Jul 2026	SCHEDULE 13G
16 Jul 2026	Form 4: Bvf Partners L P/IL, 10% owner and 9 others · XOMA Royalty Corp Disposed of 7,593,303 shares (Tender Offer)
16 Jul 2026	SCHEDULE 13D/A

Comments